Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011220
Filing Date
2025-08-12
Accepted
2025-08-12 16:05:39
Documents
92
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ganx-20250630x10q.htm   iXBRL 10-Q 1744718
2 EX-31.1 ganx-20250630xex31d1.htm EX-31.1 10966
3 EX-31.2 ganx-20250630xex31d2.htm EX-31.2 10123
4 EX-32.1 ganx-20250630xex32d1.htm EX-32.1 11607
  Complete submission text file 0001558370-25-011220.txt   7934035

Data Files

Seq Description Document Type Size
5 EX-101.SCH ganx-20250630.xsd EX-101.SCH 60332
6 EX-101.CAL ganx-20250630_cal.xml EX-101.CAL 58737
7 EX-101.DEF ganx-20250630_def.xml EX-101.DEF 230444
8 EX-101.LAB ganx-20250630_lab.xml EX-101.LAB 526969
9 EX-101.PRE ganx-20250630_pre.xml EX-101.PRE 414108
95 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20250630x10q_htm.xml XML 1314276
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40237 | Film No.: 251206608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)